Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure

Name: Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
Published: 2025
License: Public Domain

McMaster University · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

atrial-fibrillation na surgery

atrial fibrillation (af), vte, anticoagulation, atrial fibrillation, surgery, oral anticoagulant, blood thinner, doac, interruption, pause, interventional, na

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure

Related documents